Fig. 2

Overall survival after ALPPS, rescue ALPPS, and TSH/PVE. In this sub-analysis, patients who underwent rescue ALPPS due to insufficient hypertrophy after an initial TSH/PVE approach were excluded from the ALPPS group and analyzed separately. Here, no difference in OS after TSH/PVE (2.8 years, 95% CI 2.1–3.6), ALPPS (2.3 years, 95% CI 1.5–3.2), and rescue ALPPS (2.8 years, 95% CI 2.3–3.3, p = 0.971, log rank) was observed. CI, confidence interval; OS, overall survival